1. Home
  2. BRKRP vs CCIA Comparison

BRKRP vs CCIA Comparison

Compare BRKRP & CCIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRKRP
  • CCIA
  • Stock Information
  • Founded
  • BRKRP N/A
  • CCIA N/A
  • Country
  • BRKRP United States
  • CCIA
  • Employees
  • BRKRP 11396
  • CCIA N/A
  • Industry
  • BRKRP Biotechnology: Laboratory Analytical Instruments
  • CCIA
  • Sector
  • BRKRP Industrials
  • CCIA
  • Exchange
  • BRKRP Nasdaq
  • CCIA Nasdaq
  • Market Cap
  • BRKRP N/A
  • CCIA N/A
  • IPO Year
  • BRKRP N/A
  • CCIA 2023
  • Fundamental
  • Price
  • BRKRP $316.25
  • CCIA $25.20
  • Analyst Decision
  • BRKRP
  • CCIA
  • Analyst Count
  • BRKRP 0
  • CCIA 0
  • Target Price
  • BRKRP N/A
  • CCIA N/A
  • AVG Volume (30 Days)
  • BRKRP N/A
  • CCIA N/A
  • Earning Date
  • BRKRP N/A
  • CCIA N/A
  • Dividend Yield
  • BRKRP N/A
  • CCIA N/A
  • EPS Growth
  • BRKRP N/A
  • CCIA N/A
  • EPS
  • BRKRP N/A
  • CCIA N/A
  • Revenue
  • BRKRP N/A
  • CCIA N/A
  • Revenue This Year
  • BRKRP N/A
  • CCIA N/A
  • Revenue Next Year
  • BRKRP N/A
  • CCIA N/A
  • P/E Ratio
  • BRKRP N/A
  • CCIA N/A
  • Revenue Growth
  • BRKRP N/A
  • CCIA N/A
  • 52 Week Low
  • BRKRP N/A
  • CCIA N/A
  • 52 Week High
  • BRKRP N/A
  • CCIA N/A
  • Technical
  • Relative Strength Index (RSI)
  • BRKRP N/A
  • CCIA 47.34
  • Support Level
  • BRKRP N/A
  • CCIA $25.03
  • Resistance Level
  • BRKRP N/A
  • CCIA $25.08
  • Average True Range (ATR)
  • BRKRP 0.00
  • CCIA 0.05
  • MACD
  • BRKRP 0.00
  • CCIA 0.01
  • Stochastic Oscillator
  • BRKRP 0.00
  • CCIA 75.00

About BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

About CCIA Carlyle Credit Income Fund 8.75% Series A Preferred Shares due 2028

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: